Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Warns Second Ningbo, China, OTC Firm In Two Weeks On Violations

Aug 27 2019

• By Malcolm Spicer

The Great Wall of China on the background and chinese red flag - Image

Related Content

False Documents Land Chinese OTC Firm In Real Regulatory Trouble With US FDA

Aug 20 2019

Warnings Up As FDA Trims Its List Of Uninspected OTC Drug Manufacturers

Dec 14 2018

Additional Topics

China Asia Pacific United States OTC Drugs FDA Enforcement Advertising, Marketing & Sales Commercial Companies Compliance Distribution Ingredients Manufacturing Policy Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window